Clinical Trial Update: A Study of Lebrikizumab in Adults With Nummular Eczema [Phase 3]

View source ↗

Summary

This clinical trial update notes a Phase 3 study of Lebrikizumab in adults with nummular eczema, with status currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nummular Eczema

Drugs mentioned

• Lebrikizumab (lebrikizumab)

Snippet

Sponsor: Almirall, S.A. | Conditions: Nummular Eczema | Phase 3 | Status: NOT_YET_RECRUITING